DESIGN THERAPEUTICS INC (DSGN) Stock Income Statement
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 230.00K | 830.00K | |||
| Operating Expenses | 78.19M | 67.59M | 35.83M | 8.56M | 2.74M | |||
| Research and Development | 57.06M | 48.61M | 24.78M | 6.06M | 1.65M | |||
| Selling, General, and Administrative Expenses | 21.13M | 18.98M | 11.05M | 2.50M | 1.09M | |||
| Operating Income | -78.19M | -67.59M | -35.83M | -8.33M | -1.91M | |||
| Other Income/Expense | 11.33M | 4.29M | 300.00K | 50.00K | -140.00K | |||
| Income Before Taxes | -66.86M | -63.31M | -35.53M | -8.28M | -2.05M | |||
| Net Income | -66.86M | -63.31M | -35.53M | -8.28M | -2.05M | |||
| EBITDA | -77.65M | -67.18M | -35.70M | -8.32M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.19 | -1.14 | -0.77 | -0.15 | -0.04 | |||
| Non GAAP EPS | -1.20 | -1.14 | -0.86 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -3600.00% | -246.99% | |||
| Operating Profit Margin | N/A | N/A | N/A | -3621.74% | -230.12% | |||
All data in USD